Search Results - "Sill, Heinz"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Clinical implications of subclonal TP53 mutations in acute myeloid leukemia by Prochazka, Katharina T, Pregartner, Gudrun, Rücker, Frank G, Heitzer, Ellen, Pabst, Gabriel, Wölfler, Albert, Zebisch, Armin, Berghold, Andrea, Döhner, Konstanze, Sill, Heinz

    Published in Haematologica (Roma) (01-03-2019)
    “…The role of subclonal mutations, defined by a variant allele frequency of <20%, has not been addressed in acute myeloid leukemia yet. We, therefore, analyzed…”
    Get full text
    Journal Article
  5. 5

    Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs by Zebisch, Armin, Hatzl, Stefan, Pichler, Martin, Wölfler, Albert, Sill, Heinz

    “…Acute myeloid leukemia (AML) is caused by malignant transformation of hematopoietic stem or progenitor cells and displays the most frequent acute leukemia in…”
    Get full text
    Journal Article
  6. 6

    RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis by Zebisch, Armin, Caraffini, Veronica, Sill, Heinz

    “…RAF kinase inhibitor protein (RKIP) is an essential regulator of intracellular signaling. A somatic loss of RKIP expression is a frequent event in solid human…”
    Get full text
    Journal Article
  7. 7

    Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness by Grandits, Alexander Michael, Nguyen, Chi Huu, Schlerka, Angela, Hackl, Hubert, Sill, Heinz, Etzler, Julia, Heyes, Elizabeth, Stoiber, Dagmar, Grebien, Florian, Heller, Gerwin, Wieser, Rotraud

    Published in Leukemia (01-10-2021)
    “…Despite recent approval of targeted drugs for acute myeloid leukemia (AML) therapy, chemotherapy with cytosine arabinoside and anthracyclines remains an…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3Kδ in Mature B-cell Malignancies by Cooney, Jeffrey D, Lin, An-Ping, Jiang, Daifeng, Wang, Long, Suhasini, Avvaru N, Myers, Jamie, Qiu, ZhiJun, Wölfler, Albert, Sill, Heinz, Aguiar, Ricardo C T

    Published in Clinical cancer research (01-03-2018)
    “…Aberrant activation of the B-cell receptor (BCR) is implicated in the pathogenesis of mature B-cell tumors, a concept validated in part by the clinical success…”
    Get full text
    Journal Article
  17. 17

    Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations by Dutta, Sayantanee, Moritz, Jennifer, Pregartner, Gudrun, Thallinger, Gerhard G., Brandstätter, Ilona, Lind, Karin, Rezania, Simin, Lyssy, Freya, Reinisch, Andreas, Zebisch, Armin, Berghold, Andrea, Wölfler, Albert, Sill, Heinz

    Published in Annals of hematology (01-04-2022)
    “…TP53 aberrations are found in approximately 10% of patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) and are considered early…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20